‘To provide clarity on future governance’: Ozempic-maker Novo Nordisk to shake up board; move comes after 9,000 layoffs
Denmark’s Novo Nordisk, the pharmaceutical giant behind blockbuster drugs Ozempic and Wegovy, is set for a major boardroom shake-up amid internal disagreements and growing competitive pressure in the weight-loss drug market. The company on Tuesday announced that it will replace more than half of its 12-member board, including its chair, following a dispute with its…